Ro Khanna (D-Calif.) posted a video on TikTok informing his 400,000 followers of “breaking news” that “the Trump ...
1d
Medpage Today on MSNPatients Struggle With Lack of Consistent Coverage for New Weight-Loss DrugsTreatment prices that can top hundreds of dollars monthly even after discounts make it hard for many people to afford these ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Hims & Hers co-founder and CEO Andrew Dudum said the company will pivot and focus on different offerings such as its ...
from $46.54 to $ 94.50 Ozempic (semaglutide) for Type 2 diabetes (and other indications), from $56.95 to $135.43. "Medicare beneficiaries are often blindsided when they suddenly have to pay much more ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
The expected out-of-pocket costs for commonly used drugs like Eliquis and Ozempic have surged for Medicare beneficiaries in ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes months after drugmaker Novo Nordisk told the agency ...
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes. In the intervening years, a lucrative industry of telehealth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results